ArticleMikrochimica acta2025
Rapid antigen test based on gold nanoparticles embedded with highly sensitive surface-enhanced Raman scattering probes for detecting antigen concentrations below the visual detection limit.
Article in Mikrochimica acta, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
The COVID-19 pandemic has proven that people expect medically high accuracy, sensitivity, and rapid testing for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) detection. These needs have led to developing various testing methods and platforms to replace reverse transcription polymerase chain reaction (RT-PCR), the golden standard in diagnostics. Rapid antigen testing (RAT) using gold nanoparticles (AuNPs) has been developed to compensate for the shortcomings of RT-PCR. However, RAT still shows less sensitive results because it is judged by sight only. Here, we applied gold-nanobridged nanogap particles (Au-NNPs) to conventional lateral flow assay (LFA) technology for high-sensitivity testing of samples containing antigen concentration below the visual detection limit through surface-enhanced Raman scattering (SERS) signal detection. By using Raman dye-embedded Au-NNPs showing susceptible Raman signals instead of simply using gold nanoparticles, the sensitivity of the conventional RAT has been significantly increased. Therefore, it was possible to increase the sensitivity of RAT combined with simplicity and rapidity of the approach. These developments will lead to characterization applications of bio-nanotechnology and nanoparticles for health and social issues.
Indexed as
Identifiers
40341421What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.